1. Stewart BW, Wild CP. World Cancer Report.2014; P.12.

2. Cannistra, SA. Cancer of the ovary. N Engl J Med 2004; 351: 2519-29. doi.10.1056/NEJMra041842

3. Tinger A, Waldron T, Peluso N, Katin MJ, Dosoretz DE, Blitzer PH, et al. Effective palliative radiation therapy in advanced and recurrent ovarian carcinoma. Int J Radiat 2001; 51:1256-63. doi. 10.1016/S0360-3016(01)01733-3

4. Guppy AE, Nathan PD, Rustin GJS. Epithelial ovarian cancer. Clin Oncol 2005; 17:399-411. doi.10.1016/j.clon.2005.05.009

5. Devita VT, Heliman S, Rosenberg SA. Cancer. Prin Pract Oncol 2001; 1: 4450-4

6. Colombo N. Ovarian cancer. Crit Rev Oncol Hematol 2006.60:59-79. doi. 10.1016/j.critrevonc.2006.03.004

7. Reynolds EA, Moller KA. A review and an update on the screening of epithelial ovarian cancer. Curr Probl Cancer 2006; 30:203. doi:10.1016/j.currproblcancer.2006.06.001

8. Gomezraposo C, Mendiola M, Barriuso J, Hardisson D, Redondo A. Molecular characterization of ovarian cancer by gene expression profiling. Gynecol Oncol 2010; 118:88-92. doi. 10.1016/j.ygyno.2010.03.012

9. Grover SR, Quinn MA. Is there any value in bimanual pelvic examination as a screening test? Med J Aust 1995; 162:408-10. doi:10.5694/j.1326-5377.1995.tb139967.x

10. Speicher M, Antonarakis SE, Motulsky AG. Human genetics problems and approaches. 1th ed. Springer Sci Bus Med Publication.2009 ;P.230-52.

11. Sun G, Yan J, Noltner K, Feng J, Li H, Sarkis DA, et al. SNPs in human miRNA genes affect biogenesis and function. Rna 2009; 15:1640-51. doi.10.1261/rna.1560209

12. Ma XP, Zhang T, Peng B, Yu L, Jiang DK. Association between microRNA polymorphisms and cancer risk based on the findings of 66 case control studies. Plos One 2013; 8:79584. doi.10.1371/journal.pone.0079584

13. Takahashi RU, Miyazaki H, Ochiya T. The roles of microRNAs in breast cancer. Cancers 2015; 7:598-616. doi.10.3390/cancers7020598

14. Esquelakerscher A, Slack FJ. Oncomirs microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-69. doi. 10.1038/nrc1840

15. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon C, et al. MicroR-19 is a key oncogenic component of mir17-92. Genes Dev 2009; 23:2839-49. doi.10.1101/gad.1861409

16. Shan Y, Shen N, Han L, Chen Q, Zhang J, Long X, et al. MicroRNA-499 Rs3746444 polymorphism and biliary atresia. Dig Liver Dis 2016; 48:423-8. doi.10.1016/j.dld.2015.11.014

17. Chen W, Shao D, Gu H, Gong J, Zhang J. Has mir 499 rs3746444 T/C polymorphism is associated with increased risk of coronary artery disease in a Chinese population. Acta Cardiol Sin 2017; 33:34. doi. 10.6515/ACS20160303A

18. Mu K, Wu ZZ, Yu JP, Guo W, Wu N, Wei LJ, et al. Meta-analysis of the association between three microRNA polymorphisms and breast cancer susceptibility. Oncotarget 2017; 8:68809. doi. 10.18632/oncotarget.18516

19. Hu M, Zhao L, Hu S, Yang J. The association between two common polymorphisms in MicroRNAs and hepatocellular carcinoma risk in Asian population. PLos One 2013; 8:57012. doi.10.1371/journal.pone.0057012

20. Ni J, Huang Y. Role of polymorphisms in miR146a and miR149 and miR196a2 and miR499 in the development of ovarian cancer in a Chinese population. Int J Clin Exp Pathol 2016; 9:5706-11.

21. Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP, et al. miR499 regulates mitochondrial dynamics by targeting calcineurin and dynamin related protein1. Nat Med 2011; 17:71. doi.10.1038/nm.2282

22. Naderi M, Hashemi M, Khorgami P, Koshki M, Ebrahimi M, Amininia S, et al. Lack of association between miRNA146a rs2910164 and miRNA499 rs3746444 gene polymorphisms and susceptibility to pulmonary Tuberculosis. IJMCM 2015; 4:40.

23. Liu Y, Xiong L, Zhou Y, Zheng B, Liu T, Xie W. Association of three polymorphisms rs11614913 rs2910146 and rs3746444 in miRNA196a2 miRNA146a and miRNA499 with inflammatory bowel disease a systematic review and meta-analysis. Gast Res Pract 2018;2:144-51.doi.org/10.1155/2018/7295131

24. Thakur N, Singhal P, Mehrotra R, Bharadwaj M. Impacts of single nucleotide polymorphisms in three microRNAs on the susceptibility to cervical cancer among Indian women. Biosci Rep 2019; 39:71-6. doi. 10.1042/BSR20180723

25. Zou D, Liu C, Zhang Q, Li X, Qin G, Huang Q, Meng Y, Chen L, Wei J. Association between polymorphisms in microRNAs and ischemic stroke in an Asian population evidence based on 6,083 cases and 7,248 controls. Clin Int Ag2018; 13:1709.

26. doi.org/10.2147/CIA.S174000

27. Lukacs J, Soltesz B, Penyige A, Nagy B, Poka R. Identification of miR146a and miR196a 2 single nucleotide polymorphisms at patients with high grade serous ovarian cancer. J Biotechnol 2019; 297:54-7. doi.10.1016/j.jbiotec.2019.03.016

28. Liu X, Xu B, Li S, Zhang B, Mao P, Qian B, et al. Association of SNPs in miR146a miR196a2 and miR499 with the risk of endometrial ovarian cancer. Acta Biochim Biophys Sin 2015; 47:564-6. doi. 10.1093/abbs/gmv042